Mcneil and Argus Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 6 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and ARCSA (EC). Its GMP standing is certified by SAHPRA (ZA), CDSCO (India) and NAFDAC (NG). Customs aggregates show $265 of exports covering 1 molecule to 1 destination in 2026 so far.
| Site | FDA FEI |
|---|---|
| ambala cantt, India | Not on file |
| Rampur, India | Not on file |
| Sundumbili, South Africa | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 2 | 1 |
| FDA (GH) | 1 | None |
| ARCSA (EC) | 1 | None |
| CDSCO (India) | 1 | 2 |
| ANPP (DZ) | 1 | None |
| SAHPRA (ZA) | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $265 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Mcneil and Argus Pharmaceuticals, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.